Publicacións en colaboración con investigadores/as de Massachusetts General Hospital (3)

2022

  1. A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

    Journal of Neurodevelopmental Disorders, Vol. 14, Núm. 1

  2. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative

    PLoS genetics, Vol. 18, Núm. 11, pp. e1010367

2021

  1. TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines

    Human Vaccines and Immunotherapeutics